Factors associated with IgG antibody response following inactivated COVID-19 vaccination in children aged 3-17 years

Background The factors affecting the vaccine-induced humoral immune response in children's groups have not been fully clarified. This study takes COVID-19 vaccination as a model to determine the factors related to the IgG seropositivity of children aged 3 to 17 after vaccination with inactivated COVID-19 vaccine. Methods This single-center retrospective study included 1,706 children aged 3 to 17 who were vaccinated with at least one dose of inactivated whole virus COVID-19 vaccine between July 2021 and November 2022 (306 with one dose, 1,400 with two doses). The colloidal gold method was used to qualitatively evaluate the IgG antibody response. Data such as demographic characteristics, disease after vaccination, sports activities during vaccination, underlying diseases, medication, vitamin D supplementation and adverse reactions were collected through structured questionnaires. Univariate and multivariate logistic regression were used to identify factors related to seroconversion, and subgroup analysis was carried out on the two groups by age. Results In the adjusted two-dose cohort, compared with children aged 3–5 years, those aged 6–12 years (OR = 0.67, 95% CI 0.52–0.87) and 13–17 years (OR = 0.12, 95% CI 0.07–0.21) had lower odds of seroconversion. Post-vaccination illness (OR = 3.94, 95% CI 2.62–5.91), vitamin D supplementation (OR = 1.28, 95% CI 1.01–1.62), and adverse reactions (OR = 2.52, 95% CI 1.67–3.80) were significantly associated with higher odds, whereas peri-vaccination physical activity (OR = 0.51, 95% CI 0.38–0.69) was significantly associated with lower odds. In the adjusted one-dose cohort, age 6–12 years (vs. 3–5 years: OR = 0.12, 95% CI 0.05–0.28) and post-vaccination illness (OR = 10.81, 95% CI 4.55–25.67) remained significantly associated with seroconversion. In age-stratified analyses of the two-dose cohort, adverse reactions were significantly associated with lower odds in children aged 3–5 years (OR = 0.26, 95% CI 0.09–0.80) but higher odds in those aged 6–12 years (OR = 2.30, 95% CI 1.40–3.76) and 13–17 years (OR = 12.93, 95% CI 4.52–37.01). Conclusion Age, acute diseases after vaccination, strenuous sports activities before and after vaccination, vitamin D supplementation, and adverse reactions are all independently related to the IgG seroconversion after children's inactivated COVID-19 vaccine.

Authors

Institutions

Publication Details

Journal
Frontiers in Medicine
Published
2026-11-16
DOI
https://doi.org/10.3389/fmed.2026.1987417
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Factors associated with IgG antibody response following inactivated COVID-19 vaccination in children aged 3-17 years

Gongbo Zeng, Suling Wu, Linlin Wang, Xinfeng Zhao
2 links
Frontiers in Medicine
SARS-CoV-2 and COVID-19 Research
article

Factors associated with IgG antibody response following inactivated COVID-19 vaccination in children aged 3-17 years

Gongbo Zeng, Suling Wu, Linlin Wang, Xinfeng Zhao
article en

Abstract

Background The factors affecting the vaccine-induced humoral immune response in children's groups have not been fully clarified. This study takes COVID-19 vaccination as a model to determine the factors related to the IgG seropositivity of children aged 3 to 17 after vaccination with inactivated COVID-19 vaccine. Methods This single-center retrospective study included 1,706 children aged 3 to 17 who were vaccinated with at least one dose of inactivated whole virus COVID-19 vaccine between July 2021 and November 2022 (306 with one dose, 1,400 with two doses). The colloidal gold method was used to qualitatively evaluate the IgG antibody response. Data such as demographic characteristics, disease after vaccination, sports activities during vaccination, underlying diseases, medication, vitamin D supplementation and adverse reactions were collected through structured questionnaires. Univariate and multivariate logistic regression were used to identify factors related to seroconversion, and subgroup analysis was carried out on the two groups by age. Results In the adjusted two-dose cohort, compared with children aged 3–5 years, those aged 6–12 years (OR = 0.67, 95% CI 0.52–0.87) and 13–17 years (OR = 0.12, 95% CI 0.07–0.21) had lower odds of seroconversion. Post-vaccination illness (OR = 3.94, 95% CI 2.62–5.91), vitamin D supplementation (OR = 1.28, 95% CI 1.01–1.62), and adverse reactions (OR = 2.52, 95% CI 1.67–3.80) were significantly associated with higher odds, whereas peri-vaccination physical activity (OR = 0.51, 95% CI 0.38–0.69) was significantly associated with lower odds. In the adjusted one-dose cohort, age 6–12 years (vs. 3–5 years: OR = 0.12, 95% CI 0.05–0.28) and post-vaccination illness (OR = 10.81, 95% CI 4.55–25.67) remained significantly associated with seroconversion. In age-stratified analyses of the two-dose cohort, adverse reactions were significantly associated with lower odds in children aged 3–5 years (OR = 0.26, 95% CI 0.09–0.80) but higher odds in those aged 6–12 years (OR = 2.30, 95% CI 1.40–3.76) and 13–17 years (OR = 12.93, 95% CI 4.52–37.01). Conclusion Age, acute diseases after vaccination, strenuous sports activities before and after vaccination, vitamin D supplementation, and adverse reactions are all independently related to the IgG seroconversion after children's inactivated COVID-19 vaccine.

Frontiers in MedicineVol. 13
Hangzhou Children's Hospital (CN)
Good health and well-being
SARS-CoV-2 and COVID-19 Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon